1.25
A PLUS-quotedCompany
Open
The business model of the Specialty Group is;(a) to research and develop novel, 'specialty' (not 'general-purpose') intra-operative magnetic resonance (MR) scanners for use in the clinical management of cancer,(b) to offer the Group's proprietary scanners to clinical service providers for 'outright purchase' and(c) to set-up wholly or jointly owned and/or operated 'dedicated' Clinical Assessment and Treatment Service (CATS) centres, such as Breast Cancer CATS using the Group's proprietary scanners.